Form EFFECT Artiva Biotherapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 14, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Artiva plans Phase 3 trial and data updates for AlloNK in 2026
- Airwheel SE3SX AI Wheel Luxury Suitcase Wins 2026 WGA for Smart Electric Riding Carry-On Hand Luggage
- Rocket Lab Successfully Launches 16th Electron Mission Of The Year, Solidifies Status as World’s Leading Small Launch Provider
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
